Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the CROPS 2022: Improving Agriculture Through Genomics Conference
15. Juni 2022 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science...
Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic
08. März 2022 08:30 ET
|
Yield10 Bioscience, Inc.
-Acre-scale seed production planned in spring 2022 -First winter PHA Camelina planting expected in fall 2022 -Research program to produce PHA co-polymers is underway WOBURN, Mass., March 08, 2022...
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
19. Januar 2021 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced successful field testing of prototype lines of the...
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Camelina Platform for Producing PHB Biomaterials to Improve Water Quality at International Scientific Conference
04. Oktober 2019 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Yield10 Bioscience Files U.S. Patent Application Covering New Technology Enabling Low-cost Production of PHA-based Biomaterials in Camelina
17. Juni 2019 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 17, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Metabolix Completes $10 Million Sale of Biopolymer Assets to CJ CheilJedang
19. September 2016 16:05 ET
|
Metabolix
WOBURN, Mass., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX) announced today that it has completed the sale of its biopolymer intellectual property and certain equipment and...
Metabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang
22. August 2016 16:05 ET
|
Metabolix
WOBURN, Mass., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX) announced today that it has entered into a binding letter of intent (“LOI”) with CJ CheilJedang Corporation (“CJ”)...
Metabolix to Highlight Mirel PHA Biopolymers in Packaging Applications at SustPack 2016
07. April 2016 09:00 ET
|
Yield10 Bioscience, Inc.
CAMBRIDGE, Mass., April 07, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today it...